Bleilevens, C.; Soppert, J.; Hoffmann, A.; Breuer, T.; Bernhagen, J.; Martin, L.; Stiehler, L.; Marx, G.; Dreher, M.; Stoppe, C.;
et al. Macrophage Migration Inhibitory Factor (MIF) Plasma Concentration in Critically Ill COVID-19 Patients: A Prospective Observational Study. Diagnostics 2021, 11, 332.
https://doi.org/10.3390/diagnostics11020332
AMA Style
Bleilevens C, Soppert J, Hoffmann A, Breuer T, Bernhagen J, Martin L, Stiehler L, Marx G, Dreher M, Stoppe C,
et al. Macrophage Migration Inhibitory Factor (MIF) Plasma Concentration in Critically Ill COVID-19 Patients: A Prospective Observational Study. Diagnostics. 2021; 11(2):332.
https://doi.org/10.3390/diagnostics11020332
Chicago/Turabian Style
Bleilevens, Christian, Josefin Soppert, Adrian Hoffmann, Thomas Breuer, Jürgen Bernhagen, Lukas Martin, Lara Stiehler, Gernot Marx, Michael Dreher, Christian Stoppe,
and et al. 2021. "Macrophage Migration Inhibitory Factor (MIF) Plasma Concentration in Critically Ill COVID-19 Patients: A Prospective Observational Study" Diagnostics 11, no. 2: 332.
https://doi.org/10.3390/diagnostics11020332
APA Style
Bleilevens, C., Soppert, J., Hoffmann, A., Breuer, T., Bernhagen, J., Martin, L., Stiehler, L., Marx, G., Dreher, M., Stoppe, C., & Simon, T.-P.
(2021). Macrophage Migration Inhibitory Factor (MIF) Plasma Concentration in Critically Ill COVID-19 Patients: A Prospective Observational Study. Diagnostics, 11(2), 332.
https://doi.org/10.3390/diagnostics11020332
